MPH Health Care AG

DB:93M1 Stock Report

Market Cap: €100.2m

MPH Health Care Future Growth

Future criteria checks 0/6

MPH Health Care's revenue and earnings are forecast to decline at 60.2% and 65.7% per annum respectively while EPS is expected to decline by 152.5% per annum.

Key information

-65.7%

Earnings growth rate

-152.5%

EPS growth rate

Pharmaceuticals earnings growth21.5%
Revenue growth rate-60.2%
Future return on equityn/a
Analyst coverage

Low

Last updated18 Dec 2024

Recent future growth updates

Recent updates

MPH Health Care's (FRA:93M1) Profits Appear To Have Quality Issues

Oct 17
MPH Health Care's (FRA:93M1) Profits Appear To Have Quality Issues

MPH Health Care AG (FRA:93M1) Held Back By Insufficient Growth Even After Shares Climb 28%

Sep 06
MPH Health Care AG (FRA:93M1) Held Back By Insufficient Growth Even After Shares Climb 28%

MPH Health Care AG (FRA:93M1) Held Back By Insufficient Growth Even After Shares Climb 30%

Jun 13
MPH Health Care AG (FRA:93M1) Held Back By Insufficient Growth Even After Shares Climb 30%

Shaky Earnings May Not Tell The Whole Story For MPH Health Care (FRA:93M1)

Sep 15
Shaky Earnings May Not Tell The Whole Story For MPH Health Care (FRA:93M1)

A Look At The Fair Value Of MPH Health Care AG (FRA:93M1)

Sep 02
A Look At The Fair Value Of MPH Health Care AG (FRA:93M1)

We're Interested To See How MPH Health Care (FRA:93M1) Uses Its Cash Hoard To Grow

Oct 02
We're Interested To See How MPH Health Care (FRA:93M1) Uses Its Cash Hoard To Grow

We're Not Worried About MPH Health Care's (FRA:93M1) Cash Burn

Jun 19
We're Not Worried About MPH Health Care's (FRA:93M1) Cash Burn

Earnings and Revenue Growth Forecasts

DB:93M1 - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025433912-21
12/31/2024817611-31
6/30/2024118119-1-1N/A
3/31/20247675-2-2N/A
12/31/20233430-2-2N/A
9/30/20233340-1-1N/A
6/30/20233150-1-1N/A
3/31/2023313900N/A
12/31/2022312900N/A
9/30/202210-20-1-1N/A
6/30/2022-11-68-1-1N/A
3/31/20221-39-1-1N/A
12/31/202114-9-1-1N/A
9/30/202118-12-1-1N/A
6/30/202122-14-1-1N/A
3/31/202113-42-2-2N/A
12/31/20203-70-3-3N/A
9/30/202020-37-2-2N/A
6/30/202038-3-1-1N/A
3/31/2020394-1-1N/A
12/31/20194111-1-1N/A
9/30/201919-1300N/A
6/30/2019-3-3711N/A
3/31/201921033N/A
12/31/2018453755N/A
9/30/2018646311N/A
6/30/20188490-2-2N/A
3/31/20185961N/A-1N/A
12/31/20173432N/A1N/A
9/30/20172245N/A0N/A
6/30/20171058N/A0N/A
3/31/20171069N/A-3N/A
12/31/2016980N/A-5N/A
9/30/20168390N/A-2N/A
6/30/2016156100N/A1N/A
3/31/201621091N/A1N/A
12/31/201526383N/A0N/A
9/30/201523943N/A1N/A
6/30/20152143N/A3N/A
3/31/20152174N/A1N/A
12/31/20142195N/A0N/A
9/30/20142266N/A-3N/A
6/30/20142327N/A-6N/A
3/31/20142297N/A-5N/A
12/31/20132276N/A-4N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 93M1's earnings are forecast to decline over the next 3 years (-65.7% per year).

Earnings vs Market: 93M1's earnings are forecast to decline over the next 3 years (-65.7% per year).

High Growth Earnings: 93M1's earnings are forecast to decline over the next 3 years.

Revenue vs Market: 93M1's revenue is expected to decline over the next 3 years (-60.2% per year).

High Growth Revenue: 93M1's revenue is forecast to decline over the next 3 years (-60.2% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 93M1's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 11:41
End of Day Share Price 2024/12/18 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MPH Health Care AG is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward AcklinFirst Berlin Equity Research GmbH
Cosmin FilkerGBC AG
Thomas WisslerHauck Aufhäuser Investment Banking